Craif raises $33M to bring AI urine diagnostics to the U.S.

Craif, an AI urine analysis diagnostics company, raised $33 million in Series D funding, CEO Ryuichi Onose tells Axios.

Why it matters: It's starting in pancreatic cancer, where frequent late diagnosis creates demand for earlier, noninvasive detection.